Eli Lilly (LLY) is a publicly traded Healthcare sector company. As of August 19, 2026, LLY trades at $1,224.74 with a market cap of $1.05T and a P/E ratio of 40.91. LLY moved +3.49% today. Year to date, LLY is +14.06%; over the trailing twelve months it is +75.59%. Its 52-week range spans $623.78 to $1,249.45. Analyst consensus is strong buy with an average price target of $1,382.65. Rallies surfaces LLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for LLY shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1,224.74 |
| Market Cap | $1.05T |
| P/E Ratio | 40.91 |
| EPS | $29.84 |
| Dividend Yield | 1.73% |
| 52-Week High | $1,249.45 |
| 52-Week Low | $623.78 |
| Volume | 1.81M |
| Avg Volume | 0 |
| Revenue (TTM) | $79.67B |
| Net Income | $26.71B |
| Gross Margin | 83.40% |
20 analysts cover LLY: 0 strong buy, 18 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,382.65.